|
1
|
Ferro A, Peleteiro B, Malvezzi M, Bosetti
C, Bertuccio P, Levi F, Negri E, La Vecchia C and Lunet N:
Worldwide trends in gastric cancer mortality (1980–2011), with
predictions to 2015, and incidence by subtype. Eur J Cancer.
50:1330–1344. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kanda M, Shimizu D, Nomoto S, Takami H,
Hibino S, Oya H, Hashimoto R, Suenaga M, Inokawa Y, Kobayashi D, et
al: Prognostic impact of expression and methylation status of
DENN/MADD domain-containing protein 2D in gastric cancer. Gastric
Cancer. 18:288–296. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fujii S, Kitayama J, Kaisaki S, Sasaki S,
Seto Y, Tominaga O, Tsuno N, Umetani N, Yokota H, Kitamura K, et
al: Carcinoembryonic antigen mRNA in abdominal cavity as a useful
predictor of peritoneal recurrence of gastric cancer with serosal
exposure. J Exp Clin Cancer Res. 21:547–553. 2002.PubMed/NCBI
|
|
4
|
Zhao P, Lu Y, Jiang X and Li X:
Clinicopathological significance and prognostic value of CD133
expression in triple-negative breast carcinoma. Cancer Sci.
102:1107–1111. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Thompson EW, Newgreen DF and Tarin D:
Carcinoma invasion and metastasis: A role for
epithelial-mesenchymal transition? Cancer Res. 65:5991–5995. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cho RW and Clarke MF: Recent advances in
cancer stem cells. Curr Opin Genet Dev. 18:48–53. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
John A and Tuszynski G: The role of matrix
metalloproteinases in tumor angiogenesis and tumor metastasis.
Pathol Oncol Res. 7:14–23. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Steeg PS: Tumor metastasis: Mechanistic
insights and clinical challenges. Nat Med. 12:895–904. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fenoglio-Preiser C, Carneiro F, Correa P,
Guildford P, Lambert R, Megraud F, Muñoz N, Powell SM, Rugge M,
Sasako M, et al: Gastric carcinoma. In: World Health Organisation
Classification of Tumours. Pathology and Genetics of Tumours of the
Digestive System. IARC Press. (Lyon). 35–52. 2000.
|
|
10
|
Crippa MP: Urokinase-type plasminogen
activator. Int J Biochem Cell Biol. 39:690–694. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Look MP, van Putten WL, Duffy MJ, Harbeck
N, Christensen IJ, Thomssen C, Kates R, Spyratos F, Fernö M,
Eppenberger-Castori S, et al: Pooled analysis of prognostic impact
of urokinase-type plasminogen activator and its inhibitor PAI-1 in
8377 breast cancer patients. J Natl Cancer Inst. 94:116–128. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pulukuri SMK and Rao JS: Small interfering
RNA directed reversal of urokinase plasminogen activator
demethylation inhibits prostate tumor growth and metastasis. Cancer
Res. 67:6637–6646. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dass K, Ahmad A, Azmi AS, Sarkar SH and
Sarkar FH: Evolving role of uPA/uPAR system in human cancers.
Cancer Treat Rev. 34:122–136. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kaneko T, Konno H, Baba M, Tanaka T and
Nakamura S: Urokinase-type plasminogen activator expression
correlates with tumor angiogenesis and poor outcome in gastric
cancer. Cancer Sci. 94:43–49. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lee DH, Yang Y, Lee SJ, Kim KY, Koo TH,
Shin SM, Song KS, Lee YH, Kim YJ, Lee JJ, et al: Macrophage
inhibitory cytokine-1 induces the invasiveness of gastric cancer
cells by up-regulating the urokinase-type plasminogen activator
system. Cancer Res. 63:4648–4655. 2003.PubMed/NCBI
|
|
16
|
Champelovier P, Boucard N, Levacher G,
Simon A, Seigneurin D and Praloran V: Plasminogen- and
colony-stimulating factor-1-associated markers in bladder
carcinoma: Diagnostic value of urokinase plasminogen activator
receptor and plasminogen activator inhibitor type-2 using
immunocytochemical analysis. Urol Res. 30:301–309. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rosanò L, Varmi M, Salani D, Di Castro V,
Spinella F, Natali PG and Bagnato A: Endothelin-1 induces tumor
proteinase activation and invasiveness of ovarian carcinoma cells.
Cancer Res. 61:8340–8346. 2001.PubMed/NCBI
|
|
18
|
Yonemura Y, Fujimura T, Ninomiya I, Kim
BS, Bandou E, Sawa T, Kinoshita K, Endo Y, Sugiyama K and Sasaki T:
Prediction of peritoneal micrometastasis by peritoneal lavaged
cytology and reverse transcriptase-polymerase chain reaction for
matrix metalloproteinase-7 mRNA. Clin Cancer Res. 7:1647–1653.
2001.PubMed/NCBI
|
|
19
|
Kilkenny C, Browne W, Cuthill IC, Emerson
M and Altman DG: NC3Rs Reporting Guidelines Working Group: Animal
research Animal research: Reporting in vivo experiments: the ARRIVE
guidelines. Br J Pharmacol. 160:1577–1579. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Japanese Gastric Cancer Association:
Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric
Cancer. 14:113–123. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kang JH, Lee SI, Lim DH, Park KW, Oh SY,
Kwon HC, Hwang IG, Lee SC, Nam E, Shin DB, et al: Salvage
chemotherapy for pretreated gastric cancer: A randomized phase III
trial comparing chemotherapy plus best supportive care with best
supportive care alone. J Clin Oncol. 30:1513–1518. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shimizu M, Cohen B, Goldvasser P, Berman
H, Virtanen C and Reedijk M: Plasminogen activator uPA is a direct
transcriptional target of the JAG1-Notch receptor signaling pathway
in breast cancer. Cancer Res. 71:277–286. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Qiu X, Guo S, Wu H, Chen J and Zhou Q:
Identification of Wnt pathway, uPA, PAI-1, MT1-MMP, S100A4 and
CXCR4 associated with enhanced metastasis of human large cell lung
cancer by DNA microarray. Minerva Med. 103:151–164. 2012.PubMed/NCBI
|
|
25
|
Berasain C, Ujue Latasa M, Urtasun R, Goñi
S, Elizalde M, Garcia-Irigoyen O, Azcona M, Prieto J and Ávila MA:
Epidermal growth factor receptor (EGFR) crosstalks in liver cancer.
Cancers (Basel). 3:2444–2461. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Valastyan S and Weinberg RA: Tumor
metastasis: Molecular insights and evolving paradigms. Cell.
147:275–292. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mutsaers SE: The mesothelial cell. Int J
Biochem Cell Biol. 36:9–16. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Na D, Liu FN, Miao ZF, Du ZM and Xu HM:
Astragalus extract inhibits destruction of gastric cancer cells to
mesothelial cells by anti-apoptosis. World J Gastroenterol.
15:570–577. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Danø K, Behrendt N, Høyer-Hansen G,
Johnsen M, Lund LR, Ploug M and Rømer J: Plasminogen activation and
cancer. Thromb Haemost. 93:676–681. 2005.PubMed/NCBI
|
|
30
|
Mekkawy AH, Morris DL and Pourgholami MH:
Urokinase plasminogen activator system as a potential target for
cancer therapy. Future Oncol. 5:1487–1499. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Koochekpour S, Sartor O, Hiraiwa M, Lee
TJ, Rayford W, Remmel N, Sandhoff K, Minokadeh A and Patten DY:
Saposin C stimulates growth and invasion, activates p42/44 and
SAPK/JNK signaling pathways of MAPK and upregulates uPA/uPAR
expression in prostate cancer and stromal cells. J Androl.
7:147–158. 2005.
|
|
32
|
Binder BR, Mihaly J and Prager GW:
uPAR-uPA-PAI-1 interactions and signaling: A vascular biologist's
view. Thromb Haemost. 97:336–342. 2007.PubMed/NCBI
|
|
33
|
Li XF, Yan PJ and Shao ZM: Downregulation
of miR-193b contributes to enhance urokinase-type plasminogen
activator (uPA) expression and tumor progression and invasion in
human breast cancer. Oncogene. 28:3937–3948. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pluskota E, Soloviev DA and Plow EF:
Convergence of the adhesive and fibrinolytic systems: Recognition
of urokinase by integrin alpha Mbeta 2 as well as by the urokinase
receptor regulates cell adhesion and migration. Blood.
101:1582–1590. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Blasi F and Sidenius N: The urokinase
receptor: Focused cell surface proteolysis, cell adhesion and
signaling. FEBS Lett. 584:1923–1930. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Montuori N, Cosimato V, Rinaldi L, Rea
VEA, Alfano D and Ragno P: uPAR regulates pericellular proteolysis
through a mechanism involving integrins and fMLF-receptors. Thromb
Haemost. 109:309–318. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Grove LM, Southern BD, Jin TH, White KE,
Paruchuri S, Harel E, Wei Y, Rahaman SO, Gladson CL, Ding Q, et al:
Urokinase-type plasminogen activator receptor (uPAR) ligation
induces a raft-localized integrin signaling switch that mediates
the hypermotile phenotype of fibrotic fibroblasts. J Biol Chem.
289:12791–12804. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Nowicki TS, Zhao H, Darzynkiewicz Z,
Moscatello A, Shin E, Schantz S, Tiwari RK and Geliebter J:
Downregulation of uPAR inhibits migration, invasion, proliferation,
FAK/PI3K/Akt signaling and induces senescence in papillary thyroid
carcinoma cells. Cell Cycle. 10:100–107. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sheng S: The urokinase-type plasminogen
activator system in prostate cancer metastasis. Prostate Cancer:
New Horizons in Research and Treatment. Cher ML, Honn KV and Raz A:
Springer. 151–160. 2002.
|
|
40
|
Francis RM, Romeyn CL, Coughlin AM,
Nagelkirk PR, Womack CJ and Lemmer JT: Age and aerobic training
status effects on plasma and skeletal muscle tPA and PAI-1. Eur J
Appl Physiol. 114:1229–1238. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Malinowsky K, Wolff C, Berg D, Schuster T,
Walch A, Bronger H, Mannsperger H, Schmidt C, Korf U, Höfler H, et
al: uPA and PAI-1-related signaling pathways differ between primary
breast cancers and lymph node metastases. Transl Oncol. 5:98–104.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Huber AV, Saleh L, Bauer S, Husslein P and
Knöfler M: TNFalpha-mediated induction of PAI-1 restricts invasion
of HTR-8/SVneo trophoblast cells. Placenta. 27:127–136. 2006.
View Article : Google Scholar : PubMed/NCBI
|
